XLRN

Acceleron Pharma Inc

Price:

178.75

USD

Volume:

7,201,419.00

United States | Biotechnology

-107.69 %

Upside

As of 2024-09-13, the Fair Value of Acceleron Pharma Inc (XLRN) is -13.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 178.75 USD, the upside of Acceleron Pharma Inc is -107.69%.

Note: valuation result may not be accurate due to the company's negative EPS.

178.75 USD

Stock Price

-13.75 USD

Fair Price

Peter Lynch's formula is:

Acceleron Fair Value

= Earnings Growth Rate x TTM EPS
Acceleron Fair Value

= 5.00 x -2.75
Acceleron Fair Value

= -13.75
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

- | - | - | - | - | 5Y Avg | |

Net income | - | - | - | - | - | - |

YoY growth | - | - | - | - | - | -% |

Market Cap (mil) | 10,792.92 |

P/E | |

Forward P/E |

EPS | -2.75 |

Avg earnings growth rate | -% |

TTM earnings | -254.86 |